{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T04:25:24Z","timestamp":1785817524649,"version":"3.56.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,11,12]],"date-time":"2022-11-12T00:00:00Z","timestamp":1668211200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,11,12]],"date-time":"2022-11-12T00:00:00Z","timestamp":1668211200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the Clinical Science and Technology Innovation Program of the Hospital Development Center, Shanghai","award":["SHDC12018110"],"award-info":[{"award-number":["SHDC12018110"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1007\/s00417-022-05856-7","type":"journal-article","created":{"date-parts":[[2022,11,12]],"date-time":"2022-11-12T07:03:58Z","timestamp":1668236638000},"page":"1091-1100","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Elevated expression of interleukin-27, IL-35, and decreased IL-12 in patients with thyroid-associated ophthalmopathy"],"prefix":"10.1007","volume":"261","author":[{"given":"Pengbo","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xibo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wangdong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,12]]},"reference":[{"key":"5856_CR1","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.648732","volume":"12","author":"S Fang","year":"2021","unstructured":"Fang S, Lu Y, Huang Y, Zhou H, Fan X (2021) Mechanisms that underly T cell immunity in Graves\u2019 orbitopathy. Front Endocrinol (Lausanne) 12:648732. https:\/\/doi.org\/10.3389\/fendo.2021.648732","journal-title":"Front Endocrinol (Lausanne)"},{"key":"5856_CR2","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1056\/NEJMra0905750","volume":"362","author":"RS Bahn","year":"2010","unstructured":"Bahn RS (2010) Graves\u2019 ophthalmopathy. N Engl J Med 362:726\u2013738. https:\/\/doi.org\/10.1056\/NEJMra0905750","journal-title":"N Engl J Med"},{"key":"5856_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.653627","volume":"12","author":"TJ Smith","year":"2021","unstructured":"Smith TJ (2021) Insulin-like growth factor pathway and the thyroid. Front Endocrinol (Lausanne) 12:653627. https:\/\/doi.org\/10.3389\/fendo.2021.653627","journal-title":"Front Endocrinol (Lausanne)"},{"key":"5856_CR4","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.1167\/iovs.18-23951","volume":"59","author":"Y Lu","year":"2018","unstructured":"Lu Y, Atkins SJ, Fernando R, Trierweiler A, Mester T, Grisolia ABD, Mou P, Novaes P, Smith TJ (2018) CD34- orbital fibroblasts from patients with thyroid-associated ophthalmopathy modulate TNF-\u03b1 expression in CD34+ fibroblasts and fibrocytes. Invest Ophthalmol Vis Sci 59:2615\u20132622. https:\/\/doi.org\/10.1167\/iovs.18-23951","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"5856_CR5","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1111\/j.1365-2249.2005.02824.x","volume":"141","author":"TJ Smith","year":"2005","unstructured":"Smith TJ (2005) Insights into the role of fibroblasts in human autoimmune diseases. Clin Exp Immunol 141:388\u2013397. https:\/\/doi.org\/10.1111\/j.1365-2249.2005.02824.x","journal-title":"Clin Exp Immunol"},{"key":"5856_CR6","doi-asserted-by":"publisher","first-page":"7453260","DOI":"10.1155\/2019\/7453260","volume":"2019","author":"D \u0141acheta","year":"2019","unstructured":"\u0141acheta D, Mi\u015bkiewicz P, G\u0142uszko A, Nowicka G, Struga M, Kantor I, Po\u015blednik KB, Mirza S, Szczepa\u0144ski MJ (2019) Immunological aspects of Graves\u2019 ophthalmopathy. Biomed Res Int 2019:7453260\u20137453260. https:\/\/doi.org\/10.1155\/2019\/7453260","journal-title":"Biomed Res Int"},{"key":"5856_CR7","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1111\/j.1442-9071.2006.01190.x","volume":"34","author":"SX Yan","year":"2006","unstructured":"Yan SX, Wang Y (2006) Inhibitory effects of triptolide on interferon-gamma-induced human leucocyte antigen-DR, intercellular adhesion molecule-1, CD40 expression on retro-ocular fibroblasts derived from patients with Graves\u2019 ophthalmopathy. Clin Exp Ophthalmol 34:265\u2013271. https:\/\/doi.org\/10.1111\/j.1442-9071.2006.01190.x","journal-title":"Clin Exp Ophthalmol"},{"key":"5856_CR8","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.1365-2265.2007.02854.x","volume":"67","author":"T Bednarczuk","year":"2007","unstructured":"Bednarczuk T, Gopinath B, Ploski R, Wall JR (2007) Susceptibility genes in Graves\u2019 ophthalmopathy: searching for a needle in a haystack? Clin Endocrinol (Oxf) 67:3\u201319. https:\/\/doi.org\/10.1111\/j.1365-2265.2007.02854.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"5856_CR9","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1210\/jcem.86.2.7338","volume":"86","author":"WM Wiersinga","year":"2001","unstructured":"Wiersinga WM, Prummel MF (2001) Pathogenesis of Graves\u2019 ophthalmopathy\u2013current understanding. J Clin Endocrinol Metab 86:501\u2013503. https:\/\/doi.org\/10.1210\/jcem.86.2.7338","journal-title":"J Clin Endocrinol Metab"},{"key":"5856_CR10","doi-asserted-by":"publisher","first-page":"150","DOI":"10.5603\/ep.2014.0021","volume":"65","author":"H Miko\u015b","year":"2014","unstructured":"Miko\u015b H, Miko\u015b M, Obara-Moszy\u0144ska M, Niedziela M (2014) The role of the immune system and cytokines involved in the pathogenesis of autoimmune thyroid disease (AITD). Endokrynol Pol 65:150\u2013155. https:\/\/doi.org\/10.5603\/ep.2014.0021","journal-title":"Endokrynol Pol"},{"key":"5856_CR11","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.beem.2011.10.003","volume":"26","author":"S Iyer","year":"2012","unstructured":"Iyer S, Bahn R (2012) Immunopathogenesis of Graves\u2019 ophthalmopathy: the role of the TSH receptor. Best Pract Res Clin Endocrinol Metab 26:281\u2013289. https:\/\/doi.org\/10.1016\/j.beem.2011.10.003","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"5856_CR12","first-page":"168","volume":"12","author":"F Esfahanian","year":"2013","unstructured":"Esfahanian F, Naimi E, Doroodgar F, Jadali Z (2013) Th1\/Th2 Cytokines in patients with Graves\u2019 disease with or without ophthalmopathy. Iran J Allergy Asthma Immunol 12:168\u2013175","journal-title":"Iran J Allergy Asthma Immunol"},{"key":"5856_CR13","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1046\/j.1365-2249.2000.01335.x","volume":"121","author":"IMMJ Wakelkamp","year":"2010","unstructured":"Wakelkamp IMMJ, Gerding MN, Meer JWVD, Prummel MF, Wiersinga WM (2010) Both Th1- and Th2-derived cytokines in serum are elevated in Graves\u2019 ophthalmopathy. Clin Exp Immunol 121:453\u2013457","journal-title":"Clin Exp Immunol"},{"key":"5856_CR14","doi-asserted-by":"crossref","unstructured":"Wei H, Guan M, Qin Y, Xie C, Fu\u00a0X (2014) Circulating levels of miR-146a and IL-17 are significantly correlated with the clinical activity of Graves\u2019 ophthalmopathy. Endocr J 61:1087\u20131092","DOI":"10.1507\/endocrj.EJ14-0246"},{"key":"5856_CR15","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1007\/s00417-012-2092-7","volume":"250","author":"SE Kim","year":"2012","unstructured":"Kim SE, Jin SY, Kim KH, Sang YL (2012) Increased serum interleukin-17 in Graves\u2019 ophthalmopathy. Graefes Arch Clin Exp Ophthalmol 250:1521\u20131526","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"5856_CR16","doi-asserted-by":"crossref","unstructured":"Shi L, Ye H, Huang J, Li Y, Yang H (2021) IL-38 exerts anti-inflammatory and anti-fibrotic effects in thyroid-associated ophthalmopathy. J Clin Endocrinol Metab 106:e3125e3142","DOI":"10.1210\/clinem\/dgab154"},{"key":"5856_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.107300","volume":"91","author":"Y Pan","year":"2021","unstructured":"Pan Y, Wang M, Chen X, Chen Y, Liang D (2021) Elevated IL-38 inhibits IL-23R expression and IL-17A production in thyroid-associated ophthalmopathy. Int Immunopharmacol 91:107300","journal-title":"Int Immunopharmacol"},{"key":"5856_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2019.101366","volume":"34","author":"SM Ferrari","year":"2020","unstructured":"Ferrari SM, Fallahi P, Elia G, Ragusa F, Camastra S, Paparo SR, Giusti C, Gonnella D, Ruffilli I, Shoenfeld Y, Antonelli A (2020) Novel therapies for thyroid autoimmune diseases: an update. Best Pract Res Clin Endocrinol Metab 34:101366. https:\/\/doi.org\/10.1016\/j.beem.2019.101366","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"5856_CR19","doi-asserted-by":"crossref","unstructured":"Perez-Moreiras JV, Gomez-Reino JJ, Maneiro JR, Eva PP, Romo LA, Rodr\u00edguez A, Castillo L, Aurora D, Gessa SM, Enrique EG (2018) Efficacy of tocilizumab in patients with moderate to severe corticosteroid resistant Graves orbitopathy a randomized clinical trial. Am J Ophthalmol 195:181\u2013190","DOI":"10.1016\/j.ajo.2018.07.038"},{"key":"5856_CR20","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1111\/j.1600-065X.2008.00704.x","volume":"226","author":"LW Collison","year":"2010","unstructured":"Collison LW, Vignali D (2010) Interleukin-35: odd one out or part of the family? Immunol Rev 226:248\u2013262","journal-title":"Immunol Rev"},{"key":"5856_CR21","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s12026-011-8209-y","volume":"51","author":"LL Jones","year":"2011","unstructured":"Jones LL, Vignali D (2011) Molecular interactions within the IL-6\/IL-12 cytokine\/receptor superfamily. Immunol Res 51:5\u201314","journal-title":"Immunol Res"},{"key":"5856_CR22","volume-title":"Regulation of interleukin-12 production in antigen-presenting cells","author":"Z Hua","year":"2016","unstructured":"Hua Z, Yi B, Fang W, Ma X (2016) Regulation of interleukin-12 production in antigen-presenting cells. Springer, Netherlands"},{"key":"5856_CR23","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1038\/ni.2366","volume":"13","author":"D Vignali","year":"2012","unstructured":"Vignali D, Kuchroo VK (2012) IL-12 family cytokines: immunological playmakers. Nat Immunol 13:722\u2013728","journal-title":"Nat Immunol"},{"key":"5856_CR24","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/S1074-7613(02)00324-2","volume":"16","author":"S Pflanz","year":"2002","unstructured":"Pflanz S, Timans JC, Cheung J, Rosales R, Kastelein RA (2002) IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4+ T cells. Immunity 16:779\u2013790","journal-title":"Immunity"},{"key":"5856_CR25","doi-asserted-by":"crossref","unstructured":"Collison LW, Workman CJ, Kuo TT, Boyd K, Wang Y, Vignali KM, Cross R, Sehy D, Blumberg RS, Vignali DA (2007) The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature 450:566\u2013569","DOI":"10.1038\/nature06306"},{"key":"5856_CR26","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/nri1648","volume":"5","author":"CA Hunter","year":"2005","unstructured":"Hunter CA (2005) New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions. Nat Rev Immunol 5:521\u2013531","journal-title":"Nat Rev Immunol"},{"key":"5856_CR27","doi-asserted-by":"crossref","unstructured":"Collison MW, Workman HC, Vignali D (2008) How regulatory T cells work. Nat Rev Immunol 8:523\u2013532","DOI":"10.1038\/nri2343"},{"key":"5856_CR28","doi-asserted-by":"crossref","unstructured":"Bastian D, Wu Y, Betts BC, Yu XZ (2019) The IL-12 cytokine and receptor family in graft-vs.-host disease. Front Immunol 10:988-","DOI":"10.3389\/fimmu.2019.00988"},{"key":"5856_CR29","doi-asserted-by":"crossref","unstructured":"Zhang DQ, Yang L, Zhao N, Wang R, Jia K (2016) Decreased serum IL-27 and IL-35 levels are associated with disease severity in neuromyelitis optica spectrum disorders. J Neuroimmunol 293:100\u2013104","DOI":"10.1016\/j.jneuroim.2016.03.004"},{"key":"5856_CR30","doi-asserted-by":"crossref","unstructured":"Ouyang H, Shi YB, Wang Z, Feng S, Kong\u00a0SM (2014) Decreased interleukin 35 and CD4+EBI3+T cells in patients with active systemic lupus erythematosus. Am J Med Sci 348(2):156\u2013161","DOI":"10.1097\/MAJ.0000000000000215"},{"key":"5856_CR31","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/sji.12514","volume":"85","author":"A Paradowska-Gorycka","year":"2016","unstructured":"Paradowska-Gorycka A, Sowinska A, Stypi\u0144ska B, Haladyj E, Pawlik A, Romanowska-Pr\u00f3chnicka K, Olesinska M (2016) IL-12B gene polymorphisms and IL-12 p70 serum levels among patients with rheumatoid arthritis. Scand J Immunol 85:147\u2013154","journal-title":"Scand J Immunol"},{"key":"5856_CR32","doi-asserted-by":"crossref","unstructured":"Saeed MH, Kurosh K, Zahra A, Hossein DM, Ataollahi MR (2020) Decreased serum levels of IL-27and IL-35 in patients with Graves disease. Arch Endocrinol Metab 64(5):521\u2013527","DOI":"10.20945\/2359-3997000000227"},{"key":"5856_CR33","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/art.1780310302","volume":"31","author":"FC Arnett","year":"1988","unstructured":"Arnett FC, Edworthy SM, Bloch DA, Mcshane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315\u2013324","journal-title":"Arthritis Rheum"},{"key":"5856_CR34","doi-asserted-by":"crossref","unstructured":"Mourits MP, Koornneef L, Wiersinga WM, Prummel MF, Berghout A, Gaag R (1989) Clinical criteria for the assessment of disease activity in Graves\u2019 ophthalmopathy: a novel approach. Br J Ophthalmol 73(8):639\u2013644","DOI":"10.1136\/bjo.73.8.639"},{"key":"5856_CR35","doi-asserted-by":"publisher","first-page":"e3125","DOI":"10.1210\/clinem\/dgab154","volume":"106","author":"L Shi","year":"2021","unstructured":"Shi L, Ye H, Huang J, Li Y, Wang X, Xu Z, Chen J, Xiao W, Chen R, Yang H (2021) IL-38 exerts anti-inflammatory and antifibrotic effects in thyroid-associated ophthalmopathy. J Clin Endocrinol Metab 106:e3125\u2013e3142. https:\/\/doi.org\/10.1210\/clinem\/dgab154","journal-title":"J Clin Endocrinol Metab"},{"key":"5856_CR36","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s40618-015-0322-7","volume":"39","author":"M Nowak","year":"2016","unstructured":"Nowak M, Siemi\u0144ska L, Karpe J, Marek B, Kos-Kud\u0142a B, Kajdaniuk D (2016) Serum concentrations of HGF and IL-8 in patients with active Graves\u2019 orbitopathy before and after methylprednisolone therapy. J Endocrinol Invest 39:63\u201372. https:\/\/doi.org\/10.1007\/s40618-015-0322-7","journal-title":"J Endocrinol Invest"},{"key":"5856_CR37","volume":"2015","author":"S Jie","year":"2015","unstructured":"Jie S, Li Z, Li W, Ying G, Xie M, Lv M, Fan Y, Zhi C, Zhao D, Han Y (2015) Th1, Th2, and Th17 cytokine involvement in thyroid associated ophthalmopathy. Dis Markers 2015:609593","journal-title":"Dis Markers"},{"key":"5856_CR38","doi-asserted-by":"crossref","unstructured":"Fang S, Huang Y, Wang S, Zhang Y, Luo\u00a0X (2016) IL-17A exacerbates fibrosis by promoting the proinflammatory and profibrotic function of orbital fibroblasts in TAO. J Clin Endocrinol Metab 101(8):2955\u20132965","DOI":"10.1210\/jc.2016-1882"},{"key":"5856_CR39","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.4049\/jimmunol.173.2.1171","volume":"173","author":"R Goldberg","year":"2004","unstructured":"Goldberg R, Wildbaum G, Zohar Y, Maor G, Karin N (2004) Suppression of ongoing adjuvant-induced arthritis by neutralizing the function of the p28 subunit of IL-27. J Immunol 173:1171\u20131178","journal-title":"J Immunol"},{"key":"5856_CR40","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.cyto.2011.04.020","volume":"55","author":"S Tanida","year":"2011","unstructured":"Tanida S, Yoshitomi H, Ishikawa M, Kasahara T, Murata K, Shibuya H, Ito H, Nakamura T (2011) IL-27-producing CD14(+) cells infiltrate inflamed joints of rheumatoid arthritis and regulate inflammation and chemotactic migration. Cytokine 55:237\u2013244","journal-title":"Cytokine"},{"key":"5856_CR41","doi-asserted-by":"publisher","first-page":"5527627","DOI":"10.1155\/2021\/5527627","volume":"2021","author":"X Cui","year":"2021","unstructured":"Cui X, Jiao C, Wang D, Ye Z, Ma J, Tang N, Zhang H (2021) Elevated levels of IL-27 are associated with disease activity in patients with Crohn\u2019s disease. Mediators Inflamm 2021:5527627. https:\/\/doi.org\/10.1155\/2021\/5527627","journal-title":"Mediators Inflamm"},{"key":"5856_CR42","doi-asserted-by":"crossref","unstructured":"Niedbala W, Wei XQ, Cai B, Hueber AJ, Leung BP, McInnes IB, Liew FY (2007) IL-35 is a novel cytokine with therapeutic effects against collagen-induced arthritis through the expansion of regulatory T cells and suppression of Th17 cells. Eur J Immunol 37(11):3021\u20133029","DOI":"10.1002\/eji.200737810"},{"key":"5856_CR43","doi-asserted-by":"publisher","first-page":"4823","DOI":"10.1073\/pnas.92.11.4823","volume":"92","author":"T Germann","year":"1995","unstructured":"Germann T, Szeliga J, Hess H, Storkel S, Podlaski FJ, Gately MK, Rude SE (1995) Administration of interleukin 12 in combination with type II collagen induces severe arthritis in DBA\/1 mice. Proc Natl Acad Sci USA 92:4823\u20134827","journal-title":"Proc Natl Acad Sci USA"},{"key":"5856_CR44","doi-asserted-by":"publisher","first-page":"4094","DOI":"10.4049\/jimmunol.159.8.4094","volume":"159","author":"LAB Joosten","year":"1997","unstructured":"Joosten LAB, Lubberts E, Helsen MM, Berg WBVD (1997) Dual role of IL-12 in early and late stages of murine collagen type II arthritis. J Immunol 159:4094\u20134102","journal-title":"J Immunol"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-022-05856-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00417-022-05856-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-022-05856-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,28]],"date-time":"2023-03-28T07:07:52Z","timestamp":1679987272000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00417-022-05856-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,12]]},"references-count":44,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["5856"],"URL":"https:\/\/doi.org\/10.1007\/s00417-022-05856-7","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,12]]},"assertion":[{"value":"6 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the Medical Ethics Committee of Southwest Medical University (KY2021265) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}